Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Moderna Inc
(NQ:
MRNA
)
151.01
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Moderna Inc
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Moderna to Report Third Quarter Financial Results on Thursday, November 4, 2021
October 14, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces COVAX Exercises Option to Purchase 176.5 Million Additional Doses of Moderna’s COVID-19 Vaccine for Low Income Countries in First Half of 2022
October 12, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna to Build State-of-the-Art mRNA Facility in Africa to Manufacture up to 500 Million Doses Per Year
October 07, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces the Launch of Global Fellowship Program for Young Researchers Exploring mRNA Medicines
October 06, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces European Medicines Agency Authorizes Third Dose of COVID-19 Vaccine for Immunocompromised Individuals Aged 12 Years and Older
October 05, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna to Invest in New Science Center in Cambridge, MA
September 30, 2021
From
Moderna, Inc.
Via
Business Wire
Why Some Experts Say for an Effective COVID Vaccine, Look Beyond Antibodies to T-Cells
September 28, 2021
Via
FinancialNewsMedia
Exposures
COVID-19
Moderna to Present at Chardan’s Virtual 5th Annual Genetic Medicines Conference
September 28, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces Supply Agreement with Peru for 20 Million Doses of Its COVID-19 Vaccine
September 24, 2021
From
Moderna, Inc.
Via
Business Wire
Rare Adverse Effects Continue to Fuel Covid-19 Vaccine Hesitancy, Despite Safety Breakthroughs
September 23, 2021
Via
FinancialNewsMedia
Exposures
COVID-19
Product Safety
Accelerated Development of COVID-19 Vaccines to Combat Potential for Possible Future Viral Pathogens and Variants
September 22, 2021
Via
FinancialNewsMedia
Exposures
COVID-19
Scientists Rapidly Advancing Cancer Vaccine Prospects Using Same Technology as Covid-19 Shots
September 17, 2021
Via
FinancialNewsMedia
Exposures
COVID-19
Moderna Announces Health Canada Approves its COVID-19 Vaccine
September 16, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Highlights New Clinical Data on its COVID-19 Vaccine
September 15, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces Significant Advances Across Industry-Leading mRNA Portfolio at 2021 R&D Day
September 09, 2021
From
Moderna, Inc.
Via
Business Wire
Resilience to Manufacture mRNA for Moderna’s COVID-19 Vaccine
September 08, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna and the Institute for Life Changing Medicines Announce a New Collaboration to Develop an mRNA Therapeutic for Ultra-Rare Disease, Crigler-Najjar Syndrome Type 1
September 07, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces Submission of Data to European Medicines Agency for its COVID-19 Vaccine Booster
September 03, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna to Present at Upcoming Investor Conferences in September 2021
September 02, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces Submission of Initial Data to U.S. FDA for Its COVID-19 Vaccine Booster
September 01, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Completes Submission of Biologics License Application to the U.S. Food and Drug Administration for its COVID-19 Vaccine
August 25, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna to Host Virtual R&D Day on Thursday, September 9, 2021
August 24, 2021
From
Moderna, Inc.
Via
Business Wire
New COVID-19 Vaccination Mandates Make Rapid COVID Tests More Essential Than Ever
August 19, 2021
Via
FinancialNewsMedia
Exposures
COVID-19
Moderna Announces Supply Agreement with Canada for Expanded Supply of Moderna’s COVID-19 Vaccine in 2022, in 2023 and in 2024
August 16, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces First Patient Dosed in Phase 1/2 Study of mRNA-3705 for Methylmalonic Acidemia
August 16, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces FDA Authorization of Third Dose of COVID-19 Vaccine for Immunocompromised Individuals
August 13, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces New Study Showing Its COVID-19 Vaccine Maintains Antibodies Against Variants of Concern and Interest to 6 Months
August 12, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna and Canada Announce Collaboration to Bring mRNA Manufacturing to Canada
August 10, 2021
From
ModernaTX, Inc.
Via
Business Wire
Australian Therapeutic Goods Administration Grants Provisional Registration for Moderna’s COVID-19 Vaccine
August 09, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Named Fast Company’s 2021 Best Workplace for Innovators
August 06, 2021
From
Moderna, Inc.
Via
Business Wire
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.